Profitability Ratios
| Ratio |
Value |
| GP Margin |
40.6% |
| EBIT Margin |
-21.7% |
| EBITDA Margin |
-14.2% |
| Operating Margin |
-28.2% |
| Pretax Margin |
-21.7% |
| Cont. Ops Margin |
-19.1% |
| Net Margin |
-18.8% |
| Bottom Line Margin |
-18.8% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
6.48 |
| Quick Ratio |
6.35 |
| Solvency Ratio |
-0.341 |
| Cash Ratio |
0.59 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.34 |
| Forward PEG |
-0.34 |
| Price/Book |
0.73 |
| Price/Sales |
2.51 |
| Price/FCF |
-6.51 |
| Price/Op Cash Flow |
-7.95 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0063 |
| Debt/Equity |
0.0069 |
| Debt/Capital |
0.0069 |
| Long-Term Debt/Capital |
0.0018 |
| Financial Leverage |
1.09 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.86 |
| Operating Cash Flow Ratio |
-1.196 |
| Operating Cash Flow/Sales |
-31.5% |
| Free Cash Flow/Operating Cash Flow |
122.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-67.94 |
| Interest Coverage |
-1214.6133 |
| Short-Term Operating Cash Flow Coverage |
-213.53 |
| Operating Cash Flow Coverage |
-13.24 |
| Capital Expenditure Coverage |
-4.50 |
| Dividend + Capital Expenditure Coverage |
-4.50 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
10.48 |
| EPS |
-1.966 |
| Debt/Share |
0.2519 |
| Cash/Share |
10.92 |
| Book Value/Share |
35.96 |
| Tangible BV/Share |
30.81 |
| Equity/Share |
36.13 |
| Operating Cash Flow/Share |
-3.302 |
| Capital Expenditure/Share |
0.733 |
| FCF/Share |
-4.036 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.864 |
| Earnings Before Tax/EBIT |
0.769 |
| Price/Fair Value |
0.73 |
| Debt/Market Cap |
0.0030 |
| Effective Tax Rate |
12.0% |
| Enterprise Value Multiple |
-16.71 |
FLGT - Fulgent Genetics, Inc.